4//SEC Filing
Zynerba Pharmaceuticals, Inc. 4
Accession 0001192482-15-000357
CIK 0001621443operating
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 2:25 PM ET
Size
5.3 KB
Accession
0001192482-15-000357
Insider Transaction Report
Form 4
Hanlon Suzanne M.
General Counsel
Transactions
- Award
Stock Option
2015-08-04+46,616→ 46,616 totalExercise: $14.00Exp: 2025-08-04→ Common Stock (46,616 underlying)
Footnotes (1)
- [F1]The stock option vests in sixteen equal quarterly installments beginning on November 4, 2015.
Documents
Issuer
Zynerba Pharmaceuticals, Inc.
CIK 0001621443
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001621443
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 2:25 PM ET
- Size
- 5.3 KB